Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

583 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Cavo M, Gay F, Beksac M, Pantani L, Petrucci MT, Dimopoulos MA, Dozza L, van der Holt B, Zweegman S, Oliva S, van der Velden VHJ, Zamagni E, Palumbo GA, Patriarca F, Montefusco V, Galli M, Maisnar V, Gamberi B, Hansson M, Belotti A, Pour L, Ypma P, Grasso M, Croockewit A, Ballanti S, Offidani M, Vincelli ID, Zambello R, Liberati AM, Andersen NF, Broijl A, Troia R, Pascarella A, Benevolo G, Levin MD, Bos G, Ludwig H, Aquino S, Morelli AM, Wu KL, Boersma R, Hajek R, Durian M, von dem Borne PA, Caravita di Toritto T, Zander T, Driessen C, Specchia G, Waage A, Gimsing P, Mellqvist UH, van Marwijk Kooy M, Minnema M, Mandigers C, Cafro AM, Palmas A, Carvalho S, Spencer A, Boccadoro M, Sonneveld P. Cavo M, et al. Among authors: hajek r. Lancet Haematol. 2020 Jun;7(6):e456-e468. doi: 10.1016/S2352-3026(20)30099-5. Epub 2020 Apr 30. Lancet Haematol. 2020. PMID: 32359506 Clinical Trial.
Therapy of anemia in patients with multiple myeloma.
Adam Z, Krahulová M, Spelda S, Vorlícek J, Hejlová N, Hájek R, Tomíska M. Adam Z, et al. Among authors: hajek r. Acta Med Austriaca. 1995;22(4):59-64. Acta Med Austriaca. 1995. PMID: 8835422
Current role of immunotherapy in multiple myeloma.
Hájek R, Adam Z, Krivanová A, Doubek M, Korístek Z, Vorlícek J. Hájek R, et al. Acta Med Austriaca. 1998;25(3):79-85. Acta Med Austriaca. 1998. PMID: 9816399 Review.
Second autologous transplantation for multiple myeloma patients relapsing after the first autograft -- a pilot study for the evaluation of experimental maintenance therapies. Report of the prospective non-randomized pilot study of the Czech Myeloma Group.
Krivanová A, Hájek R, Krejcí M, Scudla V, Indrák K, Bacovský J, Büchler T, Svobodník A, Adam Z, Mayer J, Vorlícek J; Czech Myeloma Group. Krivanová A, et al. Among authors: hajek r. Onkologie. 2004 Jun;27(3):275-9. doi: 10.1159/000077977. Onkologie. 2004. PMID: 15249717 Clinical Trial.
[Angiogenesis and antiangiogenic cancer therapy].
Pour L, Hájek R, Buchler T, Maisnar V, Smolej L. Pour L, et al. Among authors: hajek r. Vnitr Lek. 2004 Dec;50(12):930-8. Vnitr Lek. 2004. PMID: 15717808 Review. Czech.
583 results